| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/07/1999 | EP0906429A2 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm |
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906425A2 Vasoactive amine binding molecules |
| 04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906418A1 Methods and compositions for cellular and metabolic engineering |
| 04/07/1999 | EP0906415A1 Regeneration and augmentation of bone using mesenchymal stem cells |
| 04/07/1999 | EP0906069A1 Tissue re-surfacing with hydrogel-cell compositions |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | EP0656883B1 Cationic lipids |
| 04/07/1999 | EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins |
| 04/07/1999 | EP0605586B1 Process for controlling lepidopteran pests |
| 04/07/1999 | CN1213407A Compositions and method for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/06/1999 | US5892070 Transgenic non-human mammals producing oligosaccharides and glycoconjugates |
| 04/06/1999 | US5892014 DNA encoding a protease-activated receptor 3 |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5892001 Epithelium-derived T-cell factor antibodies |
| 04/06/1999 | US5892000 From hybridomas 2g6 and b14; for immunoassay test kit used in diagnosis of athlerosclerosis and diabetes |
| 04/06/1999 | US5891997 Receptor for oncostatin M |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891723 Large granular lymphocyte leukemia associated virus |
| 04/06/1999 | US5891706 Hybridoma cell line; therapy and diagnosis of autoimmune skin disorders, antitumor agents |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891700 Receptor-type phosphotyrosine phosphatase-γ |
| 04/06/1999 | US5891691 Method of producing a cell carrying an excess of mammalian centromeres and the cell line carrying an excess of mammalian centromeres |
| 04/06/1999 | US5891690 A process which reduces the presence of replication competent virus; for large scale production of infectious e1-deleted virions; for gene therapy of cystic fibrosis, duchenne muscular dystrophy; anticarcinogenic |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891679 TNF-alpha muteins and a process for preparing them |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891666 Genes encoding LSIRF polypeptides |
| 04/06/1999 | US5891665 Rna subsequence comprising a 5' signal sequence of a non-structural gene linked to a second heterologous sequence downstream; enhanced for increased protein production |
| 04/06/1999 | US5891652 Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides |
| 04/06/1999 | US5891648 Reaction-based selection for expression of and concentration of catalytic moieties |
| 04/06/1999 | US5891639 Telomerase activity assays |
| 04/06/1999 | US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies. |
| 04/06/1999 | US5891558 Biopolymer foams for use in tissue repair and reconstruction |
| 04/06/1999 | US5891504 Flavor composition |
| 04/06/1999 | US5891455 Process for producing an implant from cell cultures |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/06/1999 | CA2228084A1 Agent for promoting proliferation of hematopoietic stem cells |
| 04/06/1999 | CA2221433A1 Selective expansion of target cell populations |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA2064705C Methods for culturing hcv in eukaryotic cells |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340480C Transient expression system for producing recombinant protein |
| 04/01/1999 | WO1999015702A1 Normalized nucleic acid libraries and methods of production thereof |
| 04/01/1999 | WO1999015697A1 ALLELIC VARIANTS OF THE PHOSPHOLIPASE C-η1 GENE ASSOCIATED WITH BIPOLAR DISORDER |
| 04/01/1999 | WO1999015685A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015683A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | WO1999015679A1 Petal-specific promoter and method for obtaining plants having flowers with no petals |
| 04/01/1999 | WO1999015675A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/01/1999 | WO1999015668A2 Banana proteins, dna, and dna regulatory elements associated with fruit development |
| 04/01/1999 | WO1999015664A1 Insulin-like polypeptide and uses therefor |
| 04/01/1999 | WO1999015663A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 04/01/1999 | WO1999015661A1 Cell growth regulator |
| 04/01/1999 | WO1999015660A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 04/01/1999 | WO1999015658A2 Human regulatory molecules |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015650A1 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| 04/01/1999 | WO1999015647A1 A potential effector for the grb7 family of signalling proteins |
| 04/01/1999 | WO1999015641A1 Non-primate lentiviral vectors and packaging systems |
| 04/01/1999 | WO1999015637A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015629A1 Methods and devices for the long-term culture of hematopoietic progenitor cells |
| 04/01/1999 | WO1999015628A1 Methods and compositions for binding hematopoietic stem cells |
| 04/01/1999 | WO1999015625A1 A medium to promote islet cell survival |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015551A1 Novel receptor |
| 04/01/1999 | WO1999015550A1 Ucp3 genes |
| 04/01/1999 | WO1999015199A1 Antigen presenting mesenchymal stem cells |
| 04/01/1999 | WO1999015190A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | WO1999015001A1 Method for producing stable chlorophyll deficient plants and plants obtained with such a method |
| 04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 04/01/1999 | WO1999002552A3 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1999001551A3 Novel inhibitor of cellular proliferation |
| 04/01/1999 | WO1998057665A3 The use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue |
| 04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 04/01/1999 | WO1998054313A3 Dna methyltransferase genomic sequences and antisense oligonucleotides |
| 04/01/1999 | WO1998054301A3 Transplants for myocardial scars and method and cellular preparations therefor |
| 04/01/1999 | WO1998054214A9 Hypersensitive response elicitor fragments and uses thereof |
| 04/01/1999 | WO1998053856A9 Methods for the detection, treatment, and prevention of neurodegeneration |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | WO1998052964A9 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 04/01/1999 | WO1998050554A3 Enterococcus faecalis polynucleotides and polypeptides |
| 04/01/1999 | WO1998050430A3 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 04/01/1999 | WO1998044874A9 Neocartilage and methods of use |
| 04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |